Prondzynski, M. (16 June 2017). Evaluation of MYBPC3 trans-splicing and gene replacement as therapeutic options in human iPSC-Derived cardiomyocytes. Molecular Therapy / Nucleic Acids, 7, . doi:10.1016/j.omtn.2017.05.008
ISBD Zitierstil"Evaluation of MYBPC3 trans-splicing and gene replacement as therapeutic options in human iPSC-Derived cardiomyocytes / Maksymilian Prondzynski, Elisabeth Krämer, Sandra D. Laufer, Aya Shibamiya, Ole Pless, Frederik Flenner, Oliver J. Müller, Julia Münch, Charles Redwood, Arne Hansen, Monica Patten, Thomas Eschenhagen, Giulia Mearini, Lucie Carrier" Molecular Therapy / Nucleic Acids .
MLA ZitierstilProndzynski, Maksymilian. "Evaluation of MYBPC3 Trans-splicing and Gene Replacement As Therapeutic Options in Human IPSC-Derived Cardiomyocytes." Molecular Therapy / Nucleic Acids 7 (16 June 2017).